| Financial Year |
March 31 2023 |
| Monetary Funds |
2,022,564,654.47 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
519,263,055.26 |
| Advances to Suppliers |
139,542,609.45 |
| Other Receivables |
517,683,292.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
56,548,269.26 |
| Dividend Receivable |
-- |
| Inventories |
36,920,753,400.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
20,821,679.51 |
| Other Current Assets |
732,368,464.70 |
| Total Current Assets |
40,958,743,176.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
190,979,238.77 |
| Investment Properties |
227,948,782.05 |
| Fixed Assetes |
73,675,373.65 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
33,359,713.61 |
| R&D expenses |
-- |
| Goodwill |
11,603,740.50 |
| Long-Term Deferred and Prepaid Expenses |
1,338,183.92 |
| Deferred Income Tax Assets |
1,566,257,120.15 |
| Other Non-Current Assets |
7,827,908,918.09 |
| Sub-Total of Non-Current Assets |
11,062,773,442.29 |
| Total Assets |
52,021,516,618.98 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
3,234,537,419.56 |
| Accounts Received In Advance |
22,797,829.84 |
| Employee Compensation Payable |
30,471,279.37 |
| Taxes Payable |
1,462,845,734.88 |
| Interest Payable |
-- |
| Dividend Payable |
12,429,762.78 |
| Other payables |
961,148,712.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,115,800,407.65 |
| Other Current Liabilities |
689,534,507.01 |
| Sub-Total of Current Liabilities |
16,236,634,576.79 |
| Long-term Loans |
21,709,631,006.44 |
| Bonds Payable |
1,765,429,993.11 |
| Long-Term Accounts Payable |
62,827,836.51 |
| Special Payable |
-- |
| Estimatied Liabilities |
39,780,000.00 |
| Deferred Income Tax Liabilities |
1,008,357,205.10 |
| Other Non-Current Liabilities |
72,007,415.35 |
| Sub-Total of Non-Current Liabilities |
24,840,481,695.00 |
| Total Liabilities |
41,077,116,271.79 |
| Paid-In Capital(Or Share Stock) |
740,777,597.00 |
| Capital Surplus |
327,514,574.72 |
| Surplus Reserve |
259,608,994.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,349,857,999.09 |
| Minority Stockholder's Interest |
2,074,677,256.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,869,723,090.85 |
| Owner's Equity（Stockholder's Equity） |
10,944,400,347.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
52,021,516,618.98 |
